Skip to content

C. Andrade

4 papers in the library · publishing 1991-2022

Papers

Sort Most recent Most cited

Insights for the Use of Ketamine From Randomized Controlled Trials That Compared Ketamine With Electroconvulsive Therapy in Severe Depression.

The Journal of Clinical Psychiatry March 28, 2022 C. Andrade

Five randomized controlled trials (RCTs) have compared racemic ketamine, mostly administered intravenously in the dose of 0.5 mg/kg across 40-45 minutes, with right unilateral or bilateral electroconvulsive therapy (ECT). These RCTs were conducted in samples of severely ill patients with mostly unipolar depression (with or without psychotic features) who were referred for ECT. Of these, 2 RCTs...

Ketamine and Electroconvulsive Therapy for Depression.

Journal of neurosurgical anesthesiology October 1, 2018 C. Andrade

K anesthesia was introduced about half a century ago. In recent decades, this drug, in subanesthetic doses, has also demonstrated efficacy for off-label indications including treating acute and chronic pain, treating agitation, treating depression, and inducing sedation. Thus, there are studies of subanesthetic dosing with ketamine for treating pain in emergency medicine settings, treating...

MEDITATION FROM AN INDIAN PERSPECTIVE

Indian Journal of Psychiatry October 1, 1991 A. C. Andrade, C. Andrade

In our personal lives, we are often consulted by relatives, friends and non-mental health professional colleagues for problems of a situational nature, or problems of living, which rarely warrant a psychiatric diagnosis. We cannot undertake formal psychotherapy in this population, nor are drugs or conventional behariour therapy procedures (such as Jacobson's progressive relaxation) quite...

Meditation Versus Medication

Indian Journal of Psychiatry 1991 C. Andrade, A. C. Andrade

We report two cases whose psychiatric dysfunction failed to respond to pharmaco-therapy, but which dramatically 'melted' with the practice of transcendental meditation (TM). Case 1: R., a 55 year old businessman, was diagnosed as Panic Disorder (severe) with Agoraphobia (mild) (American Psychiatric Association, 1987). Over 3 years of illness, he had received alprazolam (2 mg/day), lorazepam (6...